These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25701380)

  • 21. Effect of Pictorial Cigarette Pack Warnings on Changes in Smoking Behavior: A Randomized Clinical Trial.
    Brewer NT; Hall MG; Noar SM; Parada H; Stein-Seroussi A; Bach LE; Hanley S; Ribisl KM
    JAMA Intern Med; 2016 Jul; 176(7):905-12. PubMed ID: 27273839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA withdraws from fight over graphic warning labels on cigarette packs.
    Printz C
    Cancer; 2013 Jul; 119(13):2361. PubMed ID: 23775432
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
    Greene MF
    Semin Perinatol; 2015 Nov; 39(7):520-3. PubMed ID: 26428020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey.
    Tomar SL; Asma S
    J Periodontol; 2000 May; 71(5):743-51. PubMed ID: 10872955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
    Matlock A; Allan N; Wills B; Kang C; Leikin JB
    Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paediatric labelling requirements. Implications for pharmacokinetic studies.
    Wilson JT; Kearns GL; Murphy D; Yaffe SJ
    Clin Pharmacokinet; 1994 Apr; 26(4):308-25. PubMed ID: 8013163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
    Uhl K; Kennedy DL; Kweder SL
    Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cigarette smoking and clinically significant drug interactions.
    Schein JR
    Ann Pharmacother; 1995 Nov; 29(11):1139-48. PubMed ID: 8573960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
    Marroum PJ; Gobburu J
    Clin Pharmacokinet; 2002; 41(3):161-9. PubMed ID: 11929317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug interactions with tobacco smoking. An update.
    Zevin S; Benowitz NL
    Clin Pharmacokinet; 1999 Jun; 36(6):425-38. PubMed ID: 10427467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing and user testing new pharmacy label formats-A study to inform labelling standards.
    Tong V; Aslani P; Raynor DK; Shipp D; Parkinson B; Lalor D; Sobey A; Gilbert A; Crofton J; Young J; Carter S; Poon W; Chitlangia S
    Health Expect; 2021 Aug; 24(4):1125-1136. PubMed ID: 34076940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The changing cigarette, 1950-1995.
    Hoffmann D; Hoffmann I
    J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Information shocks and pharmaceutical firms' marketing efforts: Evidence from the Chantix black box warning removal.
    Lawler EC; Skira MM
    J Health Econ; 2022 Jan; 81():102557. PubMed ID: 34896791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the impact of U.S. and Canadian cigarette pack warning label requirements on tobacco industry profitability and the public health.
    Givel M
    Health Policy; 2007 Oct; 83(2-3):343-52. PubMed ID: 17239485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence supporting the need for considering the effects of smoking on drug disposition and effectiveness in medication practices: a systematic narrative review.
    Sohn HS; Kim H; Song IS; Lim E; Kwon M; Ha JH; Kwon JW
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):621-34. PubMed ID: 26104035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Audit of Black Box Warnings (BBWs) in the United States Food and Drug Administration (US-FDA) Database - A Five-Year Analysis.
    Bose D; Gogtay N; Goel T; Konwar M
    Curr Drug Saf; 2022; 17(1):54-58. PubMed ID: 34382527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of safety and efficacy information in drug inserts for topical prescription medications.
    Zaghi D; Maibach HI
    Am J Clin Dermatol; 2007; 8(1):43-6. PubMed ID: 17298106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication use in pregnancy and the pregnancy and lactation labeling rule.
    Sahin L; Nallani SC; Tassinari MS
    Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.